TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18534052

Group type: EXPERIMENTAL
Intervention: Brimonidine-purite 0.1% BID
Number of subjects: 207

Group type: COMPARATOR
Intervention: Brimonidine-purite 0.15% BID
Number of subjects: 207
Study: 16243338

Group type: EXPERIMENTAL
Intervention: Electrosurgical bipolar vessel sealing (EBVS)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Traditional suturing
Number of subjects: 68
Study: 11856620

Group type: EXPERIMENTAL
Intervention: Inactivated influenza vaccine (IIV)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Live, attenuated influenza vaccine (LIV)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Combination of LIV and IIV (LIV/IIV)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 10375359

Group type: EXPERIMENTAL
Intervention: ECMO treatment
Number of subjects: 26

Group type: COMPARATOR
Intervention: Conventional treatment (Control)
Number of subjects: 26
Study: 7556806

Group type: EXPERIMENTAL
Intervention: Miglitol
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Glibenclamide
Number of subjects: 100
Study: 2190537

Group type: EXPERIMENTAL
Intervention: Cepharanthin (CEP) 60 mg/day p.o.
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control (no CEP administration)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Cepharanthin (CEP)
Number of subjects: 106
Study: 340643

Group type: EXPERIMENTAL
Intervention: Intramuscular nalbuphine (3 and 6 mg or 6 and 12 mg)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Intramuscular morphine (4 mg and 8 mg)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Intramuscular nalbuphine
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Intramuscular morphine and nalbuphine
Number of subjects: 56
Study: 31163012

Group type: EXPERIMENTAL
Intervention: 30 Gy of adjuvant radiotherapy delivered in 1.5-Gy fractions twice per day over 2 weeks along with 15 mg/m2 docetaxel once per week (Cohort A)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 30 Gy of adjuvant radiotherapy with a simultaneous integrated boost to nodal levels with extranodal extension to 36 Gy in 1.8-Gy fractions twice per day (Cohort B)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Aggressive RT de-escalation
Number of subjects: 80
Study: 28524036

Group type: EXPERIMENTAL
Intervention: Three-district triage standard
Number of subjects: 1106

Group type: EXPERIMENTAL
Intervention: Four-level triage standard
Number of subjects: 1106

Group type: EXPERIMENTAL
Intervention: Three-district and four-level triage standards
Number of subjects: 1106
Study: 25757757

Group type: EXPERIMENTAL
Intervention: Statin therapy
Number of subjects: 73

Group type: COMPARATOR
Intervention: Nontreated patients
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Statin therapy and hematoma volume
Number of subjects: 73
Study: 23602498

Group type: EXPERIMENTAL
Intervention: Melatonin (10 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 20689451

Group type: EXPERIMENTAL
Intervention: NSAIDs (1200 mg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Exercise (60 min of one-legged kicking at 55% of workload maximum)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 19921356

Group type: EXPERIMENTAL
Intervention: 4 cm catheter length
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 8 cm catheter length
Number of subjects: 120
Study: 16923248

Group type: EXPERIMENTAL
Intervention: Vitamins E and C supplementation
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control (no supplementation)
Number of subjects: 22
Study: 14615303

Group type: EXPERIMENTAL
Intervention: First-order motion processing in V1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Second-order motion processing in later occipital visual areas
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cortical specialization for first- and second-order motion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Functional dissociation between first- and second-order motion
Number of subjects: 0
Study: 10815854

Group type: EXPERIMENTAL
Intervention: Troglitazone therapy
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Troglitazone
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Ciglitazone and 15-deoxy-delta-12,14-prostaglandinJ2
Number of subjects: 25
Study: 8986924

Group type: EXPERIMENTAL
Intervention: Office blood pressure measured in winter and summer
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Home blood pressure measured in winter and summer
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Daytime ambulatory blood pressure measured in winter and summer
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Night-time ambulatory blood pressure measured in winter and summer
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Average 24 h blood pressure measured in winter and summer
Number of subjects: 50
Study: 1479419

Group type: EXPERIMENTAL
Intervention: Intramuscular recombinant alpha 2b interferon (3 x 10(6)) administered every second evening for 6 months
Number of subjects: 70

Group type: COMPARATOR
Intervention: Aspecific treatment
Number of subjects: 70
Study: 6335848

Group type: EXPERIMENTAL
Intervention: Two diphtheria‐pertussis‐tetanus (DPT) immunizations 6 months apart
Number of subjects: 902

Group type: COMPARATOR
Intervention: Conventional three doses of DPT 3 months apart
Number of subjects: 902

Group type: EXPERIMENTAL
Intervention: Both immunized groups (2-dose and 3-dose)
Number of subjects: 902

Group type: EXPERIMENTAL
Intervention: Trial children (both immunized groups)
Number of subjects: 902
Study: 31215198

Group type: EXPERIMENTAL
Intervention: Nutritional counselling group (NCG) - kickboxers
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Nutritional counselling group (NCG) - runners
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (CG) - kickboxers
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (CG) - runners
Number of subjects: 40
Study: 30103079

Group type: EXPERIMENTAL
Intervention: Older-centered Integrated Health Management Model Project (OPCHMP), personalized, 2-year intervention
Number of subjects: 637

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 637

Group type: EXPERIMENTAL
Intervention: Older-centered Integrated Health Management Model Project (OPCHMP)
Number of subjects: 637
Study: 26203971

Group type: EXPERIMENTAL
Intervention: Effective earplugs
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Less effective earplugs
Number of subjects: 144

Group type: COMPARATOR
Intervention: No earplugs
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Active noise cancellation headphones with sound masking
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Active noise cancellation headphones without sound masking
Number of subjects: 144
Study: 24161018

Group type: EXPERIMENTAL
Intervention: Raltegravir plus tenofovir/emtricitabine (arm A)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Abacavir/lamivudine (arm B)
Number of subjects: 40
Study: 22410206

Group type: EXPERIMENTAL
Intervention: Duloxetine (SNRI)
Number of subjects: 483

Group type: COMPARATOR
Intervention: Escitalopram (SSRI)
Number of subjects: 483
Study: 20304399

Group type: EXPERIMENTAL
Intervention: EUS-measured maximum tumor thickness (MTT) after CRT < or = 6 mm
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: EUS-measured relative reduction in MTT (yMTT/MTT) < or = 50%
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: yMTT
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: yMTT < or = 6 mm and yMTT/MTT < or = 50%
Number of subjects: 56
Study: 18055682

Group type: EXPERIMENTAL
Intervention: Structured screening instrument conducted at ages 15/18 and 24 months
Number of subjects: 9419

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 9419
Study: 16254767

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral guided self-care
Number of subjects: 85

Group type: COMPARATOR
Intervention: Family therapy
Number of subjects: 85
Study: 12030726

Group type: EXPERIMENTAL
Intervention: Formoterol (12 microg Turbuhaler)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Salmeterol (50 microg Diskus)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Terbutaline (500 microg Turbuhaler)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 9672328

Group type: EXPERIMENTAL
Intervention: Ketoprofen 75 mg/day
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Acetaminophen 4000 mg/day
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 8032383

Group type: EXPERIMENTAL
Intervention: Laser assisted hatching
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (mechanical SUZI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Laser assisted micromanipulation (SUZI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mechanical SUZI
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Laser (PZD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mechanical (PZD)
Number of subjects: 0
Study: 2643088

Group type: EXPERIMENTAL
Intervention: Easy-listening music
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Rock music
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Self-selected music
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Dissertation (placebo-attention)
Number of subjects: 10

Group type: COMPARATOR
Intervention: No-treatment control
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Self-generated imagery with music (SIM)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Guided imagery with music (GIM)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Self-generated imagery without music (SI)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Guided imagery without music (GI)
Number of subjects: 10
Study: 787518

Group type: EXPERIMENTAL
Intervention: Indomethacin 100 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Diazepam 10 mg
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 31326480

Group type: EXPERIMENTAL
Intervention: PET MPI
Number of subjects: 322

Group type: COMPARATOR
Intervention: SPECT MPI
Number of subjects: 322
Study: 28222674

Group type: EXPERIMENTAL
Intervention: 6% HES 130/0.4 administration
Number of subjects: 120

Group type: COMPARATOR
Intervention: Sodium lactate Ringer's solution 7.5 mL/kg
Number of subjects: 120
Study: 26228686

Group type: EXPERIMENTAL
Intervention: Catheter-directed thrombolysis (CDT) through the small saphenous vein (Group A)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Catheter-directed thrombolysis (CDT) through the great saphenous vein (Group B)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Catheter-directed thrombolysis (CDT) through the popliteal vein (Group C)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Follow-up of 88 patients for 7-24 months
Number of subjects: 106
Study: 24194421

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (daily 25 mg)
Number of subjects: 94
Study: 23031470

Group type: EXPERIMENTAL
Intervention: 100 g FB/kg DM diet
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 150 g FB/kg DM diet
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (0 g FB/kg DM diet)
Number of subjects: 24

Group type: COMPARATOR
Intervention: 50 g FB/kg DM diet
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Highest level of FB (150 g FB/kg DM diet)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: All FB diets
Number of subjects: 24
Study: 19435954

Group type: EXPERIMENTAL
Intervention: Intensive insulin therapy using a closed-loop system (AP group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional insulin therapy using the sliding-scale method (SS group)
Number of subjects: 0
Study: 17302746

Group type: EXPERIMENTAL
Intervention: 1% luliconazole cream
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: 0.5% luliconazole cream
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: 0.1% luliconazole cream
Number of subjects: 241
Study: 15366590

Group type: EXPERIMENTAL
Intervention: Shuizhitong capsule (SZT)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Piracetam
Number of subjects: 85
Study: 11411424

Group type: EXPERIMENTAL
Intervention: Younger adults
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Older adults
Number of subjects: 0
Study: 10093804

Group type: EXPERIMENTAL
Intervention: Pneumatic tourniquet (T)
Number of subjects: 32

Group type: COMPARATOR
Intervention: No tourniquet (NT)
Number of subjects: 32
Study: 7811481

Group type: EXPERIMENTAL
Intervention: Preservation of annulo-papillary continuity (PAPC) during mitral valve replacement
Number of subjects: 69

Group type: COMPARATOR
Intervention: Excision of all the chordae (EC) during mitral valve replacement
Number of subjects: 69
Study: 3406428

Group type: EXPERIMENTAL
Intervention: Ceruletide (0.8 micrograms/kg/week)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 1827011

Group type: EXPERIMENTAL
Intervention: Isradipine MR 5 mg once daily
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Isradipine MR 10 mg once daily
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Isradipine given twice daily (13 +/- 2 mg total daily dose)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Modified-release isradipine (isradipine MR) once daily
Number of subjects: 32
Study: 766142

Group type: EXPERIMENTAL
Intervention: Prednisolone 5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prednisolone 3 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (0 mg)
Number of subjects: 0
Study: 30608465

Group type: EXPERIMENTAL
Intervention: Admission packets used to guide nurses' first home visit after hospital discharge
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: EHR-generated medication lists in admission packets
Number of subjects: 20
Study: 28667499

Group type: EXPERIMENTAL
Intervention: Two-stage Turnbull-Cutait coloanal anastomosis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hand-sewn coloanal anastomosis with associated lateral ileostomy
Number of subjects: 0
Study: 26197289

Group type: EXPERIMENTAL
Intervention: Multiplex PCR assay
Number of subjects: 230

Group type: COMPARATOR
Intervention: Multiplex PCR compared to culture method
Number of subjects: 230
Study: 24558079

Group type: EXPERIMENTAL
Intervention: Valsartan
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 21330250

Group type: EXPERIMENTAL
Intervention: Cobalt-chromium drug-eluting stents
Number of subjects: 11313

Group type: COMPARATOR
Intervention: Stainless steel drug-eluting stents
Number of subjects: 11313
Study: 19183164

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) with a quantified peach extract for Pru p 3, duration: 6 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) with a quantified peach extract for Pru p 3
Number of subjects: 0
Study: 17272521

Group type: EXPERIMENTAL
Intervention: Vision screening in the office
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vision screening
Number of subjects: 0
Study: 15277165

Group type: EXPERIMENTAL
Intervention: Calcium supplementation (1 g/d)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Lactation
Number of subjects: 168

Group type: COMPARATOR
Intervention: Nonlactating status
Number of subjects: 168

Group type: COMPARATOR
Intervention: Previous lactation status
Number of subjects: 168
Study: 11808847

Group type: EXPERIMENTAL
Intervention: Oxytocin (16 IU) administered intranasally to 49 subjects
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control group of 54 subjects with no prior oxytocin treatment
Number of subjects: 103
Study: 9735932

Group type: EXPERIMENTAL
Intervention: Microencapsulated lambdacyhalothrin for bednet treatment
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Microencapsulated lambdacyhalothrin for house spraying
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Both interventions (bednet and house spraying)
Number of subjects: 240
Study: 7852746

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study: 2902642

Group type: EXPERIMENTAL
Intervention: Zuclopenthixol decanoate injection (mean dosage 123 mg/week)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study: 30427829

Group type: EXPERIMENTAL
Intervention: rcAd26.MOS1.HIV‐Env vaccine (10^8 to 10^11 rcAd26 VP)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 25374187

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy (4,500 cGy of radiation at 180 cGy per day plus chemotherapy with cisplatin and 5‐fluorouracil, in the first and the end four days of radiotherapy)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Adjuvant chemoradiotherapy after surgical resection
Number of subjects: 25

Group type: COMPARATOR
Intervention: Adjuvant chemoradiotherapy for well differentiated adenocarcinoma
Number of subjects: 25
Study: 22330020

Group type: EXPERIMENTAL
Intervention: PRET at RPE13 for 30 min, 3 times per week for 8 weeks
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 26
Study: 20732940

Group type: EXPERIMENTAL
Intervention: Media Detective program
Number of subjects: 679

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 679
Study: 17981439

Group type: EXPERIMENTAL
Intervention: Flaxseed (40 g daily for 12 months)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Flaxseed
Number of subjects: 199

Group type: COMPARATOR
Intervention: Wheat germ (placebo)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 199
Study: 15514916

Group type: EXPERIMENTAL
Intervention: Corticosteroids as part of antileukemic therapy
Number of subjects: 1951
Study: 12351462

Group type: EXPERIMENTAL
Intervention: Repaglinide (4 mg t.i.d.)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Metformin (850 or 1,000 mg t.i.d., dose unchanged)
Number of subjects: 80
Study: 12564024

Group type: EXPERIMENTAL
Intervention: Bronchoalveolar lavage (BAL)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Conventional drug treatment
Number of subjects: 117
Study: 8897218

Group type: EXPERIMENTAL
Intervention: Relaxation with suggestions to increase immune system proteins
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Relaxation alone
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 90
Study: 2003706

Group type: EXPERIMENTAL
Intervention: Chlorthalidone with usual diet
Number of subjects: 697

Group type: COMPARATOR
Intervention: Placebo with usual diet
Number of subjects: 697

Group type: EXPERIMENTAL
Intervention: Atenolol with usual diet
Number of subjects: 697

Group type: COMPARATOR
Intervention: Low-sodium diet with placebo
Number of subjects: 697

Group type: EXPERIMENTAL
Intervention: Low-sodium diet with chlorthalidone
Number of subjects: 697

Group type: EXPERIMENTAL
Intervention: Weight loss diet
Number of subjects: 697
Study: 6732567

Group type: EXPERIMENTAL
Intervention: Humphrey automatic refractor
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard subjective techniques
Number of subjects: 100
Study: 30126325

Group type: EXPERIMENTAL
Intervention: Lidocaine/Phenylephrine administered with a nasal nebulizer
Number of subjects: 106

Group type: COMPARATOR
Intervention: Lidocaine/Phenylephrine administered with a nasal spray
Number of subjects: 106
Study: 26685718

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 30

Group type: COMPARATOR
Intervention: Captopril
Number of subjects: 30
Study: 24533048

Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (iNO) 80 ppm
Number of subjects: 40
Study: 23059166

Group type: EXPERIMENTAL
Intervention: Quetiapine XR (extended-release)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Quetiapine IR (immediate-release)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Quetiapine XR
Number of subjects: 139

Group type: COMPARATOR
Intervention: Quetiapine IR
Number of subjects: 139
Study: 20371128

Group type: EXPERIMENTAL
Intervention: Hydrochloride pioglitazone (group DP)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Sulfonylureas (group DS)
Number of subjects: 98
Study: 18022467

Group type: EXPERIMENTAL
Intervention: 4% articaine with 1:100,000 epinephrine (A100)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 4% articaine with 1:200,000 epinephrine (A200)
Number of subjects: 50
Study: 16792320

Group type: EXPERIMENTAL
Intervention: Aprotinin in the dose of 3 ppm KIU
Number of subjects: 109

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 109
Study: 12734059

Group type: EXPERIMENTAL
Intervention: High folate intake (highest tertile)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Lowest tertile of folate intake
Number of subjects: 177
Study: 10410585

Group type: EXPERIMENTAL
Intervention: G‐CSF
Number of subjects: 71

Group type: COMPARATOR
Intervention: GM‐CSF
Number of subjects: 71
Study: 8533869

Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside (NP) infusion for 60 min, decreasing mean arterial blood pressure to 50 mm Hg.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no NP infusion).
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside (NP) infusion for 60 min.
Number of subjects: 30
Study: 2210311

Group type: EXPERIMENTAL
Intervention: Magnesium-aspartate hydrochloride 15 mmol per day
Number of subjects: 568

Group type: COMPARATOR
Intervention: Placebo (aspartic acid)
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: Magnesium group
Number of subjects: 568
Study: 6159256

Group type: EXPERIMENTAL
Intervention: aprotinin
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: glucagon
Number of subjects: 257
Study: 31599043

Group type: EXPERIMENTAL
Intervention: 25.2 g oral patiromer plus standard of care (SOC)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 30
Study: 31651118

Group type: EXPERIMENTAL
Intervention: SIB-VMAT plus capecitabine
Number of subjects: 59

Group type: COMPARATOR
Intervention: Standard arm (image-guided VMAT plus capecitabine)
Number of subjects: 59
Study: 28188124

Group type: EXPERIMENTAL
Intervention: Computerized cognitive behavioral therapy for insomnia (CCBT‐I) as an adjunctive treatment
Number of subjects: 0
Study: 26147760

Group type: EXPERIMENTAL
Intervention: Cold acclimation (14-15 °C) for 10 days
Number of subjects: 8